HIV-R4P-dated-logo

HIV R4P is the world's first and only scientific meeting dedicated exclusively to biomedical HIV prevention research.



Welcome to HIV Research for Prevention 2014 (HIV R4P), the first global scientific meeting focused exclusively on the challenging and rapidly evolving field of biomedical HIV prevention research.

HIV R4P ushers in a new era in prevention science. This meeting builds on the best elements of the vaccine and microbicides meetings, and adds the latest research on an ever-expanding array of HIV prevention approaches and technologies. HIV R4P reflects the growing consensus that understanding, analyzing and debating the crosscutting issues that impact every field of biomedical prevention research will be central to our shared efforts to defeat this global epidemic.

Across this conference week, daily plenary sessions, 30 oral abstract and two poster sessions, along with satellites, symposia, roundtables, and networking lunches, will address the most compelling issues in the field—from the latest research on vaccines, microbicides, pre-exposure prophylaxis and treatment as prevention, to emerging prevention approaches and the challenges of implementation and access.

HIV R4P has also been designed to represent the contributions and address the needs of attendees from every field of research, and to include the unique perspectives of advocates, funders, policy-makers and private-sector leaders as well. Interaction, discussion and debate—between participants and across disciplines—will be a hallmark of R4P. To facilitate the full representation of global expertise at the meeting, 300 full and partial scholarships have been granted to leading researchers and advocates who otherwise would be unable to attend the conference.

This first biennial HIV R4P conference takes place at a critical moment in the epidemic. The search for effective biomedical HIV prevention options has progressed further and faster in recent years than at any time since the epidemic began. At the same time, we face multiple obstacles—from the challenges of providing real and sustainable access to prevention advances, to the realities of tightening budgets and the advent of laws and policies criminalizing the very lives of people at risk. Whatever our field of expertise, our efforts to reverse this epidemic must include a commitment not only to advance the science of HIV prevention, but also to support robust global responses to the epidemic and the full human rights of all people impacted by HIV.

We encourage you to break out of your conference comfort zone this week, to investigate new areas of research, and to participate in the Q&A sessions that will be part of every R4P session. We believe that interaction between fields of research, and maximizing the lessons of our shared experiences, will bring us closer to a world without AIDS. With your participation, we hope to make HIV R4P an important step on that shared journey!

conference details2

Conference Fast Facts

HIV R4P brings more than 1300 of the world's leading prevention researchers, funders and policy makers for four days of exchange, debate and direction-setting for the field. The conference features:

  • 722 abstract presentations (177 oral, 545 posters. The oral and poster counts include 29 poster discussions 65 late-breakers);
  • 4 plenary, and 17 symposia and roundtable sessions;
  • 300 international scholarships; five New Investigator Awardees;
  • Webcasts of all oral sessions– available within 24 hours;
  • An electronic archive of posters (ePosters);
  • 12 satellite sessions;
  • Networking lunches with experts in the field.

facebook logo60Twitter-logo60LinkedIn-Logo60mail-icon60

Latest Tweets

HIVR4Px Six days remain to submit #HIVpx latebreaker abstracts to #HIVR4P http://t.co/ffpZTYUtMk!
HIVR4Px 8 days remaining! Register by 4 July to receive the early rate for #HIVR4P, http://t.co/ePEIMs3esG .
HIVR4Px Don't delay! Submit your #HIVR4P conference abstracts by 2 May, http://t.co/W4barDj1n8 #HIVprevention #research
HIVR4Px Check out the latest on #HIVR4P, in our newsletter, http://t.co/iWX6ZJxiBm!